ArticleBiological trace element research2026
Labile Bound Copper (LBC) and Total Serum Copper Concentrations in Newborns and Infants.
Article in Biological trace element research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Effective markers for early detection of Wilson disease are of interest. Recently, a labile bound copper assay has been developed for the evaluation of copper disorders, which in concert with total copper concentrations can effectively detect Wilson disease in adults. Newborn labile bound copper (LBC) concentrations may also resemble those observed in adult patients with Wilson disease, as newborns exhibit low total copper concentrations and limited ceruloplasmin production. The primary goal of this study was to investigate LBC and total copper concentrations in newborns (0-4 weeks of age) and infants (5-29 weeks of age) and to compare them to those seen in adult patients with Wilson disease. Associations between LBC, LBC fraction, and total copper versus bilirubin concentrations in newborns were also investigated. Serum samples originally measured for bilirubin concentrations were analyzed for labile bound copper, labile bound copper fraction, and total serum copper by inductively coupled plasma mass spectrometry. Nearly 35% of newborns had labile bound copper fraction values that were above the adult reference interval cutoff, resembling values seen in adults with Wilson disease. Labile bound copper fraction values in pre-term newborns were higher than in full-term newborns, and pre-term newborns had lower total copper concentrations compared to full-term newborns. Finally, after adjusting for age, total copper concentrations in both newborns and infants were negatively correlated with both total bilirubin and unconjugated bilirubin. While the labile bound copper assay may not be suitable for evaluating newborns for Wilson disease, it may be a useful tool to assess copper metabolism.
Indexed as
Identifiers
40841868What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.